For health systems, providing effective value-based care involves having foundational building blocks, this chief clinical officer says. Stephanie Duggan, MD, the chief clinical officer of SSM Health, ...
Value-based care has been slowly gaining traction in the U.S. Some Rhode Island providers are trying to transition their practices away from fee-for-service and toward value-based care The key ...
Just over three-quarters of health system and hospital C-suites say they plan to increase value-based care model participation within the next two years, up from the 57% who indicated similarly back ...
SSM Health has established "foundational building blocks" to support value-based care. The chief clinical officer of SSM Health is passionate about value-based care. Stephanie Duggan, MD, became chief ...
Recent federal and state policies have been facilitating the participation of federally qualified health centers (FQHCs) in value-based payment programs to transform care delivery for underserved ...
The U.S. healthcare system is at a crossroads, embarking on a crucial transformation in how care is financed. For decades, we've operated under a fee-for-service (FFS) model, which incentivizes ...
Aledade is expanding its value-based care relationship with Humana to bring the partnership's services to rural health clinics and federally qualified health centers. The value-based care enablement ...
Analytics driven by artificial intelligence could transform value-based care by addressing long-standing inefficiencies and enabling providers to deliver better outcomes at lower costs. This is among ...
On Wall Street, health executives love to talk about “value-based care.” Since 2011, the term has popped up in earnings calls 1,800 times, health news website Stat reported in early December. The ...
ACO REACH fills a gap by providing an option for ACOs to participate in an advanced accountable payment model with global risk and a population-based payment design through up-front capitated payments ...
Evidence suggests that adoption of oncology biosimilars in Medicare value-based payment models has produced substantial cost ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results